Evidence map›Paper›PMID 32326617›Full record

ArticleInternational journal of molecular sciences2020

Role of UDP-Sugar Receptor P2Y

Nicholas Mikolajewicz, Svetlana V Komarova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CaInternational journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Special Issue ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nicholas MikolajewiczShriners Hospital for Children, Montreal, QC H4A 0A9, Canada.
Svetlana V KomarovaShriners Hospital for Children, Montreal, QC H4A 0A9, Canada.
McGill University · CA

Funding

CIHR PJT-165939Natural Sciences and Engineering Research Council of Canada RGPIN-288253
6 · The paper itself

Abstract

The purinergic (P2) receptor P2Y

Indexed as

Adenosine DiphosphateAdenosine TriphosphateAnimalsBone DensityCalciumCell LineCell ProliferationCells, CulturedCRISPR-Cas SystemsCyclic AMPGene Knockout TechniquesMiceMice, Inbred C57BLMice, KnockoutMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Adenosine DiphosphateAdenosine TriphosphateCalciumCyclic AMPMapk1 protein, mouseMapk3 protein, mouseMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3P2ry14 protein, mousePurinergic AntagonistsReceptors, Purinergic P2YUridine Diphosphate GlucoseUridine Diphosphate SugarsboneGpr105osteoblastsP2Y14purinergic receptors

Identifiers

PMID32326617
PMCPMC7216066
OpenAlexW3016423545

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.